Yu-Chieh Su

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 17

Top Venues

Journal of clinical medicine

Cancers

PloS one

International journal of molecular sciences

Kaohsiung Medical University Hospital

Kaohsiung Medical University Graduate Institute of Clinilcal Medicine (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Kaohsiung Medical University Hospital Aug 21 2018

Taiwan

Director :: Division of Hematology-Oncology

E-Da Hospital Jun 01 2016 - Aug 20 2018

Taiwan

Chief :: Division of hematology-oncology

I-Shou University College of Medicine Aug 01 2016 - Jul 31 2018

Taiwan

Associate Professor :: Meidcine

Tzu Chi University - May 31 2016

Taiwan

Associate Professor

Education History

Kaohsiung Medical University Graduate Institute of Clinilcal Medicine

Taiwan

MSC

Publications

Noha Mostafa, Po-Jen Chen, Sarah S Darwish, Yu-Chieh Su, Ming-Hua Shiao, Gary A Piazza, Ashraf H Abadi, Matthias Engel, Mohammad Abdel-Halim
N -Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents. Cancers 16 (11) (2024)
Chung-I Huang, Chien-Yu Ker, Hung-Ju Li, Yu-Ting Hsiao, Sheng-Fung Lin, Yu-Chieh Su
Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008-2020. International journal of hematology (2024)
Chung-I Huang, Chien-Yu Ker, Hung-Ju Li, Yu-Ting Hsiao, Sheng-Fung Lin, Yu-Chieh Su
Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008-2020. International journal of hematology 119 (6) (2024)
Noha Mostafa, Po-Jen Chen, Sarah S Darwish, Yu-Chieh Su, Ming-Hua Shiao, Gary A Piazza, Ashraf H Abadi, Matthias Engel, Mohammad Abdel-Halim
N -Benzylated 5-Hydroxybenzothiophene-2-carboxamides as Multi-Targeted Clk/Dyrk Inhibitors and Potential Anticancer Agents. Cancers 16 (11) (2024)
Liang-Chun Chiu, Chih-Wen Lin, Hung-Ju Li, Jian-Han Chen, Fu-Cheng Chuang, Sheng-Fung Lin, Yu Chang, Yu-Chieh Su
Incidence Trend of Follicular Lymphoma in Taiwan Compared to Japan and Korea, 2001-2019. Journal of clinical medicine 12 (4) (2023)
Liang-Chun Chiu, Chih-Wen Lin, Hung-Ju Li, Jian-Han Chen, Fu-Cheng Chuang, Sheng-Fung Lin, Yu Chang, Yu-Chieh Su
Incidence Trend of Follicular Lymphoma in Taiwan Compared to Japan and Korea, 2001-2019. Journal of clinical medicine 12 (4) (2023)
Liang-Chun Chiu, Chih-Wen Lin, Hung-Ju Li, Jian-Han Chen, Fu-Cheng Chuang, Sheng-Fung Lin, Yu Chang, Yu-Chieh Su
Incidence Trend of Follicular Lymphoma in Taiwan Compared to Japan and Korea, 2001-2019. Journal of clinical medicine 12 (4) (2023)
Liang-Chun Chiu, Chih-Wen Lin, Hung-Ju Li, Jian-Han Chen, Fu-Cheng Chuang, Sheng-Fung Lin, Yu Chang, Yu-Chieh Su
Incidence Trend of Follicular Lymphoma in Taiwan Compared to Japan and Korea, 2001-2019. Journal of clinical medicine 12 (4) (2023)
Yu-Chieh Su, Wei-Chang Lee, Chih-Chun Wang, Shyh-An Yeh, Wen-Hui Chen, Po-Jen Chen
Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas. International journal of molecular sciences 23 (24) (2022)
Yu-Chieh Su, Wei-Chang Lee, Chih-Chun Wang, Shyh-An Yeh, Wen-Hui Chen, Po-Jen Chen
Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas. International journal of molecular sciences 23 (24) (2022)
Yu-Chieh Su, Brian Chih-Hung Chiu, Hung-Ju Li, Wen-Chi Yang, Tsai-Yun Chen, Su-Peng Yeh, Ming-Chung Wang, Wen-Tsung Huang, Ming-Yang Lee, Sheng-Fung Lin
Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data. PloS one 17 (3) (2022)
Yu-Chieh Su, Wei-Chang Lee, Chih-Chun Wang, Shyh-An Yeh, Wen-Hui Chen, Po-Jen Chen
Targeting PI3K/AKT/mTOR Signaling Pathway as a Radiosensitization in Head and Neck Squamous Cell Carcinomas. International journal of molecular sciences 23 (24) (2022)
Chun-Han Su, Pau-Choo Chung, Sheng-Fung Lin, Hung-Wen Tsai, Tsung-Lung Yang, Yu-Chieh Su
Multi-Scale Attention Convolutional Network for Masson Stained Bile Duct Segmentation from Liver Pathology Images. Sensors (Basel, Switzerland) 22 (7) (2022)
Fu-Cheng Chuang, Chih-Chun Wang, Jian-Han Chen, Tzer-Zen Hwang, Shyh-An Yeh, Yu-Chieh Su
PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy. PloS one 16 (1) (2021)
Szu-Chin Li, Ching-Chih Lee, Chin-Mu Hsu, Hsien-Bin Huang, Yu-Chieh Su
IL-6 induces haptoglobin expression through activating STAT3 in human head and neck cancer. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 49 (1) (2019)
Chung-I Huang, Chih-Chun Wang, Tzong-Shyuan Tai, Tzer-Zen Hwang, Chuan-Chien Yang, Chin-Mu Hsu, Yu-Chieh Su
eIF4E and 4EBP1 are prognostic markers of head and neck squamous cell carcinoma recurrence after definitive surgery and adjuvant radiotherapy. PloS one 14 (11) (2019)
Victor C Kok, Yu-Ching Chen, Yang-Yuan Chen, Yu-Chieh Su, Ming-Chang Ku, Jung-Tsung Kuo, Go J Yoshida
Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study. Cancers 11 (7) (2019)

Yu-Chieh Su.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yu-Chieh Su